Madison, WINCT07132918Now EnrollingIRB Ready

Non-Small Cell Lung Cancer (Stage III) Clinical Trial in Madison, WI

Access cutting-edge non-small cell lung cancer (stage iii) treatment through this phase 2 clinical trial at a research site in Madison. Study-provided care at no cost to qualified participants.

Sponsored by University of Wisconsin, Madison

Quick Self-Assessment

See if you qualify for this Madison location

Preparing your pre-screening questions…

Expert Care in Madison

Access non-small cell lung cancer (stage iii) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related non-small cell lung cancer (stage iii) treatment provided free

Apply for This Madison Location

Check if you qualify for this non-small cell lung cancer (stage iii) clinical trial in Madison, WI

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Madison

    Convenient for WI residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Madison site if eligible
  4. 4Begin participation

About This Non-Small Cell Lung Cancer (Stage III) Study in Madison

The goal of this clinical trial is to compare a new way of using magnetic resonance-guided adaptive radiation therapy (MRgART) to the standard of care linear accelerator (LINAC) radiation treatment in people with cancer in the thoracic region near the heart. The main question it aims to answer is whether MRgART affects the heart differently than LINAC. Participants will: * Receive radiation therapy * Undergo MRIs and bloodwork * Complete quality of life questionnaires

Sponsor: University of Wisconsin, Madison

Who Can Participate

Inclusion Criteria

Age \> 18 years at the time of consent.
Dosimetric eligibility criteria met using endpoints from QUANTEC (\>10% of heart receives \> 25 Gy) as determined through rapid auto-planning
Participants with histologically or cytologically proven AJCC, 8th edition including:
Stage IIB, IIIA, IIIB, IIIC, or IV non-operable non-small cell lung cancer
Limited stage small cell lung cancer, once daily treatment (excluding twice per day fractionation schemes). Stage I-III N0-2 disease esophageal/esophagogastric cancer
Stage II or III thymoma/thymic carcinoma
Other cancers in the thoracic region that meet the dosimetric and other clinical trial criteria, for example lymphoma sarcoma.
Participants must have a course of daily fractionated RT planned of at least 15 treatment fractions, typically ranging from 1.8 to 4 Gy/fraction

Exclusion Criteria

Definitive clinical or radiologic evidence of metastatic disease with life expectancy \<12 months
Prior thoracic radiotherapy significantly overlapping the heart region
Contraindications to MRI
Severe, active co-morbidity defined as follows: New York Heart Association Functional Classification III/IV are not eligible.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Madison?

Yes, this clinical trial (NCT07132918) has an active research site in Madison, WI that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Non-Small Cell Lung Cancer (Stage III) Treatment Options in Madison, WI

If you're searching for non-small cell lung cancer (stage iii) treatment options in Madison, WI, this clinical trial (NCT07132918) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Madison research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced non-small cell lung cancer (stage iii) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all non-small cell lung cancer (stage iii) clinical trials near you to find additional studies recruiting in your area.

More Lung Cancer Trials in Madison, WI

See all lung cancer clinical trials recruiting in Madison — not just this study.

Browse Lung Cancer Trials in Madison →

Ready to Join in Madison?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Madison, WI